BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28350819)

  • 1. Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host.
    Loncoman CA; Hartley CA; Coppo MJ; Vaz PK; Diaz-Méndez A; Browning GF; Lee SW; Devlin JM
    PLoS One; 2017; 12(3):e0174590. PubMed ID: 28350819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Diversity of Infectious Laryngotracheitis Virus during
    Loncoman CA; Hartley CA; Coppo MJC; Vaz PK; Diaz-Méndez A; Browning GF; García M; Spatz S; Devlin JM
    Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28939604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of high-resolution melting analysis for the classification of infectious laryngotracheitis virus strains and detection of recombinant progeny.
    Fakhri O; Hartley CA; Devlin JM; Browning GF; Noormohammadi AH; Lee SW
    Arch Virol; 2019 Feb; 164(2):427-438. PubMed ID: 30421085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MinION sequencing to genotype US strains of infectious laryngotracheitis virus.
    Spatz SJ; Garcia M; Riblet S; Ross TA; Volkening JD; Taylor TL; Kim T; Afonso CL
    Avian Pathol; 2019 Jun; 48(3):255-269. PubMed ID: 30722676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Quinteros JA; Diaz-Méndez A; Thilakarathne D; Fakhri O; Vaz PK; Devlin JM
    Vaccine; 2018 Sep; 36(38):5709-5716. PubMed ID: 30104116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated vaccines can recombine to form virulent field viruses.
    Lee SW; Markham PF; Coppo MJ; Legione AR; Markham JF; Noormohammadi AH; Browning GF; Ficorilli N; Hartley CA; Devlin JM
    Science; 2012 Jul; 337(6091):188. PubMed ID: 22798607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution and Mutagenesis of Avian Infectious Laryngotracheitis Virus from Cosmid and Yeast Centromeric Plasmid Clones.
    Spatz S; García M; Fuchs W; Loncoman C; Volkening J; Ross T; Riblet S; Kim T; Likens N; Mettenleiter T
    J Virol; 2023 Apr; 97(4):e0140622. PubMed ID: 37022163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full genomic characterisation of an emerging infectious laryngotracheitis virus class 7b from Australia linked to a vaccine strain revealed its identity.
    Sabir AJ; Olaogun OM; O'Rourke D; Fakhri O; Coppo MJC; Devlin JM; Konsak-Ilievski B; Noormohammadi AH
    Infect Genet Evol; 2020 Mar; 78():104067. PubMed ID: 31678646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genome analysis of Korean field strains of infectious laryngotracheitis virus.
    La TM; Choi EJ; Lee JB; Park SY; Song CS; Choi IS; Lee SW
    PLoS One; 2019; 14(2):e0211158. PubMed ID: 30730935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and tissue tropism of natural field recombinants of infectious laryngotracheitis virus.
    Thilakarathne DS; Noormohammadi AH; Browning GF; Quinteros JA; Underwood GJ; Hartley CA; Coppo MJ; Devlin JM; Diaz-Méndez A
    Vet Microbiol; 2020 Apr; 243():108635. PubMed ID: 32273014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of live virus vaccines against infectious laryngotracheitis assessed by polymerase chain reaction-restriction fragment length polymorphism.
    Han MG; Kim SJ
    Avian Dis; 2003; 47(2):261-71. PubMed ID: 12887186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping of infectious laryngotracheitis virus using allelic variations from multiple genomic regions.
    Choi EJ; La TM; Choi IS; Song CS; Park SY; Lee JB; Lee SW
    Avian Pathol; 2016 Aug; 45(4):443-9. PubMed ID: 26956802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens.
    Helferich D; Veits J; Teifke JP; Mettenleiter TC; Fuchs W
    J Gen Virol; 2007 Mar; 88(Pt 3):732-742. PubMed ID: 17325345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Korean strains of infectious laryngotracheitis virus by nucleotide sequences and restriction fragment length polymorphism.
    Han MG; Kim SJ
    Vet Microbiol; 2001 Dec; 83(4):321-31. PubMed ID: 11600266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latency characteristics in specific pathogen-free chickens 21 and 35 days after intra-tracheal inoculation with vaccine or field strains of infectious laryngotracheitis virus.
    Thilakarathne DS; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Coppo MJC; Devlin JM
    Avian Pathol; 2020 Aug; 49(4):369-379. PubMed ID: 32352307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of the newly emerging infectious laryngotracheitis viruses in Australia.
    Agnew-Crumpton R; Vaz PK; Devlin JM; O'Rourke D; Blacker-Smith HP; Konsak-Ilievski B; Hartley CA; Noormohammadi AH
    Infect Genet Evol; 2016 Sep; 43():67-73. PubMed ID: 27223632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS; Coppo MJC; Hartley CA; Diaz-Méndez A; Quinteros JA; Fakhri O; Vaz PK; Devlin JM
    PLoS One; 2019; 14(3):e0213866. PubMed ID: 30921344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic recombination between infectious laryngotracheitis vaccine strains occurs under a broad range of infection conditions in vitro and in ovo.
    Fakhri O; Devlin JM; Browning GF; Vaz PK; Thilakarathne D; Lee SW; Hartley CA
    PLoS One; 2020; 15(3):e0229082. PubMed ID: 32119681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.